Akari therapeutics plc (AKTX)
Balance Sheet / Yearly
Jun'18Dec'17Jun'17Dec'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Dec'13Dec'12Dec'11
Assets
Current Assets:
Cash

15,069

28,106

30,118

34,098

9,662

61,429

68,919

78,772

2,718

4,016

3,327

7,657

1,104

6

Short-term investments

-

-

0

10,021

46,120

-

0

-

-

-

-

-

-

-

Prepaid expenses and other current assets

1,453

706

1,686

1,513

1,580

1,253

728

-

-

-

7

-

-

-

Receivable from related party

-

-

-

-

10

10

10

-

-

-

0

-

-

-

Short term restricted deposit

-

-

-

-

-

-

-

-

142

142

-

0

-

-

Prepaid expenses and other current assets

-

-

-

-

-

-

-

166

60

115

-

175

14

21

Total Current Assets

16,523

28,813

31,805

45,633

57,374

62,693

69,658

78,939

2,920

4,273

3,335

7,832

1,118

27

Restricted cash

521

142

142

142

142

142

142

-

-

-

0

-

-

-

Restricted deposit

-

-

-

-

-

-

-

142

-

-

-

-

-

-

Property and equipment, net

38

55

74

58

71

74

40

34

40

44

0

0

2

0

Patent acquisition costs, net

36

39

31

39

45

49

52

58

-

-

59

-

-

-

Total Assets

17,119

29,050

32,053

45,873

57,633

62,959

69,893

79,174

2,960

4,317

3,394

7,832

1,120

27

Liabilities and Shareholders' Equity
Current Liabilities:
Accounts payable

2,001

1,971

2,842

2,214

1,917

625

4,320

3,753

-

-

555

-

-

-

Accounts payable - related party

-

-

-

-

-

-

-

0

-

-

39

-

-

-

Accrued expenses

3,989

4,795

1,305

1,837

360

231

408

3,845

-

-

42

-

-

-

Loans payable - shareholders

-

-

-

-

-

-

-

3,031

-

-

533

-

-

-

Deferred shares

-

-

-

-

-

-

-

-

-

-

-

-

-

216

Liabilities related to options and warrants

2,288

5,081

4,995

7,662

14,715

15,691

16,396

27,165

984

774

0

787

630

60

Trade payables

-

-

-

-

-

-

-

-

629

296

-

652

1,697

1,379

Other accounts payable

-

-

-

-

-

-

-

-

331

614

-

579

1,255

857

Short-term convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

898

0

Total Current Liabilities

8,279

11,848

9,143

11,714

16,994

16,549

21,124

37,796

960

910

1,171

1,231

3,850

2,236

Other long term liabilities

-

-

-

-

-

-

-

-

43

38

-

0

-

-

Other long-term liability

213

48

58

56

55

52

49

46

1,027

812

0

787

630

276

Total liabilities

8,492

11,896

9,201

11,771

17,049

16,601

21,174

37,842

-

-

1,171

-

-

-

Commitments and Contingencies

0

0

0

0

0

0

0

0

0

0

0

0

-

-

Shareholders' Equity:
Share capital of GBP .01 par value Authorized: 10,000,000,000 ordinary shares; issued and outstanding: 1,525,693,393 at June 30, 2018 and December 31, 2017, respectively

22,927

22,927

18,340

18,340

18,340

18,340

18,340

18,340

927

927

11,210

675

245

225

Additional paid-in capital

105,627

104,799

92,727

90,979

88,668

87,835

87,018

86,062

34,224

34,175

2,445

25,681

13,199

9,836

Accumulated other comprehensive loss

-230

-236

-373

-280

-191

-36

156

197

-

-

46

-

-

-

Receipts on account of shares

-

-

-

-

-

-

-

-

-

-

-

-

118

75

Accumulated deficit

-119,697

-110,336

-87,842

-74,937

-66,233

-59,781

-56,796

-63,268

-34,178

-32,507

-11,479

-20,542

-16,922

-12,621

Total Shareholders' Equity

8,626

17,153

22,851

34,102

40,583

46,358

48,719

41,331

973

2,595

2,223

5,814

-3,360

-2,485

Total Liabilities and Shareholders' Equity

17,119

29,050

32,053

45,873

57,633

62,959

69,893

79,174

2,960

4,317

3,394

7,832

1,120

27